Scholarly Works - Conferences
Conference
Lupus
·
August 1, 2026
Background/Purpose: Mycophenolate compound (MMF, to represent both mycophenolate mofetil and mycophenolic acid) is an immunosuppressant used to treat Systemic Lupus Erythematosus (SLE). Due to its teratogenicity, the FDA recommends universal mycophenolate ...
Full text
Cite
Conference
Arthritis Care Res (Hoboken)
·
January 2023
OBJECTIVE: Medication nonadherence is common among patients with systemic lupus erythematosus (SLE), and adherence often fluctuates with time. Underrepresented racial minorities have disproportionately lower rates of medication adherence and more severe SL ...
Full text
Link to item
Cite
Conference
Arthritis Care Res (Hoboken)
·
July 2015
OBJECTIVE: While several regional fellowship groups conduct rheumatology objective structured clinical examinations (ROSCEs), none have been validated for use across programs. We aimed to establish agreement among subspecialty experts regarding checklist i ...
Full text
Link to item
Cite
Conference
Arthritis Rheumatol
·
July 2015
OBJECTIVE: Vitamin D modulates the immune response and blocks induction of an interferon (IFN) signature by systemic lupus erythematosus (SLE) sera. This study was undertaken to investigate the effects of vitamin D supplementation on the IFN signature in p ...
Full text
Link to item
Cite